450 related articles for article (PubMed ID: 17434910)
21. [Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis].
Hayashi N; Kumagai S
Rinsho Byori; 2010 May; 58(5):466-79. PubMed ID: 20560456
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
23. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S
Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
[TBL] [Abstract][Full Text] [Related]
24. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
25. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
[TBL] [Abstract][Full Text] [Related]
26. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis].
Ota T
Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407
[TBL] [Abstract][Full Text] [Related]
27. [Early prediction of joint destruction in rheumatoid arthritis].
Eguchi K
Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
[TBL] [Abstract][Full Text] [Related]
28. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
[TBL] [Abstract][Full Text] [Related]
29. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
Yalaoui S
Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
[TBL] [Abstract][Full Text] [Related]
30. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
Bos WH; Ursum J; de Vries N; Bartelds GM; Wolbink GJ; Nurmohamed MT; van der Horst-Bruinsma IE; van de Stadt RJ; Crusius JB; Tak PP; Dijkmans BA; van Schaardenburg D
Ann Rheum Dis; 2008 Sep; 67(9):1347-50. PubMed ID: 18388157
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.
van Venrooij WJ; Zendman AJ; Pruijn GJ
Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315
[TBL] [Abstract][Full Text] [Related]
32. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis: a meta-analysis].
Huang QS; Wan LG; Luo ZQ; Le AP; Wang WQ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2182-7. PubMed ID: 17064503
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
35. Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.
Kogure T; Tatsumi T; Fujinaga H; Niizawa A; Terasawa K
Mediators Inflamm; 2007; 2007():12367. PubMed ID: 17497027
[TBL] [Abstract][Full Text] [Related]
36. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark.
Pedersen M; Jacobsen S; Garred P; Madsen HO; Klarlund M; Svejgaard A; Pedersen BV; Wohlfahrt J; Frisch M
Arthritis Rheum; 2007 May; 56(5):1446-53. PubMed ID: 17469102
[TBL] [Abstract][Full Text] [Related]
37. [The clinical significance of cyclic citrullinated peptide antibodies: new data].
Novikov AA; Aleksandrova EN; Nasonov EL
Klin Med (Mosk); 2007; 85(8):4-9. PubMed ID: 17926481
[TBL] [Abstract][Full Text] [Related]
38. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
39. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis.
Inui N; Enomoto N; Suda T; Kageyama Y; Watanabe H; Chida K
Clin Biochem; 2008 Sep; 41(13):1074-7. PubMed ID: 18638466
[TBL] [Abstract][Full Text] [Related]
40. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.
Lee HS; Irigoyen P; Kern M; Lee A; Batliwalla F; Khalili H; Wolfe F; Lum RF; Massarotti E; Weisman M; Bombardier C; Karlson EW; Criswell LA; Vlietinck R; Gregersen PK
Arthritis Rheum; 2007 Jun; 56(6):1745-53. PubMed ID: 17530703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]